These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 31248612)
1. Activating and inhibitory killer cell immunoglobulin like receptors (KIR) genes are involved in an increased susceptibility to colorectal adenocarcinoma and protection against invasion and metastasis. Barani S; Hosseini SV; Ghaderi A Immunobiology; 2019 Sep; 224(5):681-686. PubMed ID: 31248612 [TBL] [Abstract][Full Text] [Related]
2. KIR2DS1, 2DS5, 3DS1 and KIR2DL5 are associated with the risk of head and neck squamous cell carcinoma in Iranians. Barani S; Khademi B; Ashouri E; Ghaderi A Hum Immunol; 2018 Apr; 79(4):218-223. PubMed ID: 29408295 [TBL] [Abstract][Full Text] [Related]
3. Positive association of Bx genotype, KIR2L5, KIR2DS5 and full-length KIR2DS4 with the risk of meningioma. Barani S; Taghipour M; Ghaderi A Immunobiology; 2020 Mar; 225(2):151900. PubMed ID: 31899050 [TBL] [Abstract][Full Text] [Related]
4. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer. Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262 [TBL] [Abstract][Full Text] [Related]
5. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031 [TBL] [Abstract][Full Text] [Related]
6. Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage. Canossi A; Aureli A; Del Beato T; Rossi P; Franceschilli L; De Sanctis F; Sileri P; di Lorenzo N; Buonomo O; Lauro D; Venditti A; Sconocchia G J Transl Med; 2016 Aug; 14(1):239. PubMed ID: 27519478 [TBL] [Abstract][Full Text] [Related]
8. The effects of killer cell immunoglobulin-like receptor (KIR) genes on susceptibility to HIV-1 infection in the Polish population. Zwolińska K; Błachowicz O; Tomczyk T; Knysz B; Gąsiorowski J; Zalewska M; Orzechowska BU; Sochocka M; Piasecki E Immunogenetics; 2016 May; 68(5):327-37. PubMed ID: 26888639 [TBL] [Abstract][Full Text] [Related]
9. Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations. Shastry A; Sedimbi SK; Rajalingam R; Rumba I; Kanungo A; Sanjeevi CB Ann N Y Acad Sci; 2008 Dec; 1150():133-8. PubMed ID: 19120281 [TBL] [Abstract][Full Text] [Related]
10. Association of killer-cell immunoglobulin-like receptor genes with acute myelogenous leukaemia. Alavianmehr A; Mansouri M; Ramzi M; Faghih M; Monabati A; Arandi N; Faghih Z; Farjadian S Int J Immunogenet; 2020 Dec; 47(6):512-521. PubMed ID: 32767509 [TBL] [Abstract][Full Text] [Related]
11. [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients]. Zhang HQ; Zhao JJ; Zhao YR; Guan QB; Gao L; Song HD Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):699-701. PubMed ID: 19664392 [TBL] [Abstract][Full Text] [Related]
12. [Distribution of donor-specific aKIR after unrelated allogeneic hematopoietic stem cell transplantation]. Zhang HH; He J; Bao XJ; Hu X; Wang M; Zhang J; Wu XJ Zhonghua Xue Ye Xue Za Zhi; 2017 May; 38(5):421-426. PubMed ID: 28565743 [No Abstract] [Full Text] [Related]
13. Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals. Levinson RD; Okada AA; Ashouri E; Keino H; Rajalingam R Hum Immunol; 2010 Feb; 71(2):192-4. PubMed ID: 19897003 [TBL] [Abstract][Full Text] [Related]
14. Diversity of KIRs in invasive breast cancer patients and healthy controls along with the clinical significance in ER/PR/HER2+ patients. Hematian Larki M; Barani S; Talei AR; Ghaderi A Genes Immun; 2020 Dec; 21(6-8):380-389. PubMed ID: 33257819 [TBL] [Abstract][Full Text] [Related]
15. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation. Sahin U; Dalva K; Gungor F; Ustun C; Beksac M Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412 [TBL] [Abstract][Full Text] [Related]
16. Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors. Kitpoka P; Tammakorn C; Chaisri S; Leelayuwat C; Mongkolsuk T; Thammanichanond D Hum Immunol; 2016 Jun; 77(6):470-5. PubMed ID: 27131859 [TBL] [Abstract][Full Text] [Related]
17. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation. Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438 [TBL] [Abstract][Full Text] [Related]
18. Impact of "Killer Immunoglobulin-Like Receptor /Ligand" Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival. Beksac K; Beksac M; Dalva K; Karaagaoglu E; Tirnaksiz MB PLoS One; 2015; 10(7):e0132526. PubMed ID: 26181663 [TBL] [Abstract][Full Text] [Related]
19. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis. Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169 [TBL] [Abstract][Full Text] [Related]